0001209191-23-037914.txt : 20230616
0001209191-23-037914.hdr.sgml : 20230616
20230616163126
ACCESSION NUMBER: 0001209191-23-037914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHILIPS CRAIG W.
CENTRAL INDEX KEY: 0001441383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 231021689
MAIL ADDRESS:
STREET 1: C/O KINETA, INC.
STREET 2: 219 TERRY AVE. N., SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER NAME:
FORMER CONFORMED NAME: PHILIPS CRAIG
DATE OF NAME CHANGE: 20080729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001445283
KINETA, INC./DE
KA
0001441383
PHILIPS CRAIG W.
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
0
1
0
0
President
0
Common Stock
2023-06-14
4
M
0
1382
0.14
A
34654
I
By Whetstone Ventures, LLC
Common Stock
2023-06-14
4
F
0
12666
2.82
D
54311
D
Warrats (Right to Buy)
0.14
2023-06-14
4
M
0
1382
0.00
D
2025-12-02
Common Stock
1382
0
I
By Whetstone Ventures, LLC
The Reporting Person is a member manager of Whetstone Ventures, LLC ("Whetstone") and shares voting and dispositive power over the shares held by Whetstone.
Exempt transaction pursuant to Rule 16b-3(e) for the withholding of shares of the Issuer's Common Stock by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units.
The warrants are immediately exercisable in full.
/s/ Pauline Kenny, as Attorney-in-Fact
2023-06-16